TrialThe Lancet. Oncology2025

Effect of NeuroSAFE-guided RARP versus standard RARP on erectile function and urinary continence in patients with localised prostate cancer (NeuroSAFE PROOF): a multicentre, patient-blinded, randomised, controlled phase 3 trial.

Eoin Dinneen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.